Abstract
The overactivation of μ-calpain can cause serious cell damage in several diseases. Furthermore, cell death in a number of neurodegenerative disorders is linked to the overproduction of reactive oxygen species. Therefore, antioxidants and μ-calpain inhibitors could have the therapeutic potentials to treat cell death related diseases. New chromone carboxamide derivatives 3 were synthesized to provide alternative μ-calpain inhibitors to compound 2, a conformationally constrained structural variant of MDL 28,170. Compounds 3h and 3l exhibited the most potent μ-calpain inhibitory activities (IC 50 = 0.09-0.10 μM), and were comparable to 2 in this respect (IC50 = 0.07 μM). Compound 3i showed both potent μ-calpain inhibitory activity (IC50 = 0.28 μM) and antioxidant activities in DPPH scavenging and lipid peroxidation inhibition assays.
Original language | English |
---|---|
Pages (from-to) | 1721-1728 |
Number of pages | 8 |
Journal | European Journal of Medicinal Chemistry |
Volume | 46 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2011 |
Bibliographical note
Funding Information:This work was supported by the Basic Science Research Program of the Korean National Research Foundation (NRF) funded by MEST (# 2010-0016080 ).
Keywords
- Antioxidant
- Calpain inhibitor
- Cell death
- Chromone carboxamide
- Neurodegenerative disease